Regulation of human dermal papilla cell production of insulin-like growth factor binding protein-3 by retinoic acid, glucocorticoids, and insulin-like growth factor-1

被引:0
|
作者
Hembree, JR
Harmon, CS
Nevins, TD
Eckert, RL
机构
[1] CASE WESTERN RESERVE UNIV, SCH MED, DEPT PHYSIOL & BIOPHYS, CLEVELAND, OH 44106 USA
[2] CASE WESTERN RESERVE UNIV, SCH MED, DEPT DERMATOL, CLEVELAND, OH 44106 USA
[3] CASE WESTERN RESERVE UNIV, SCH MED, DEPT REPROD BIOL, CLEVELAND, OH 44106 USA
[4] CASE WESTERN RESERVE UNIV, SCH MED, DEPT BIOCHEM, CLEVELAND, OH 44106 USA
[5] HOFFMANN LA ROCHE INC, DERMATOL RES, NUTLEY, NJ 07110 USA
关键词
D O I
10.1002/(SICI)1097-4652(199606)167:3<556::AID-JCP19>3.0.CO;2-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Insulin-like growth factor-1 (IGF1) has been reported to stimulate hair elongation and to facilitate maintenance of the hair follicle in anagen phase. However, little is known about IGF1 signaling in the hair follicle. In this study we investigate the effects of IGF1, glucocorticoids, and retinoids on dermal papilla (DP) cell production of insulin-like growth factor binding proteins (IGFBPs). IGFBPs comprise a family of IGF binding proteins that are produced and released by most cell types. They bind to IGFs to either enhance or inhibit IGF activity. In the present report we identify IGFBP-3 as being produced and released by cultured human dermal papilla (DP) cells. IGFBP-3 levels are increased fivefold by retinoic acid, eightfold by dexamethasone, and tenfold by IGF1. DP cells are known to produce IGF1, and so the observed stimulation of DP cell IGFBP-3 production by IGF1 is consistent with the idea that DP cells possess the IGF transmembrane receptor kinase and are autoregulated by IGFs. The level of another IGFBP, tentatively identified as IGFBP-2, is, in contrast, not regulated by these agents. IGFBP-3 has been shown to inhibit the activity of IGFs in a variety of systems. Our results are consistent with a model in which retinoids and glucocorticoids inhibit IGF action on DP cells and surrounding matrix cells by stimulating increased DP cell production of IGFBP-3. The IGFBP-3, in turn, forms a complex with free IGF1 to reduce the concentration of IGF1 available to stimulate hair elongation and maintenance of anagen phase. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:556 / 561
页数:6
相关论文
共 50 条
  • [1] Regulation of human dermal papilla cell production of insulin-like growth factor binding protein-2 (IGFBP-3) by retinoids, glucocorticoids, insulin-like growth factor-1 and transforming growth factor beta-1.
    Hembree, JR
    Harmon, CS
    Chandraratna, AS
    Nevins, TD
    Eckert, RL
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 684 - 684
  • [3] Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Levels in Human Milk and Prolonged Jaundice
    B Ermis
    K Apaydin
    M Can
    H Ankarali
    R Ors
    Pediatric Research, 2011, 70 : 793 - 793
  • [4] INSULIN-LIKE GROWTH FACTOR-1 AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 LEVELS IN HUMAN MILK AND PROLONGED JAUNDICE
    Ermis, B.
    Apaydin, K.
    Can, M.
    Ankarali, H.
    Ors, R.
    PEDIATRIC RESEARCH, 2011, 70 : 793 - 793
  • [5] Relationships Between Colorectal Cancer and Insulin, Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3
    Moiseenko, A. B.
    Berstein, L. M.
    Belyaeva, A. V.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S410 - S410
  • [6] The effect of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in cavernous nerve cryoablation
    Bochinski, DJ
    Hsieh, PS
    Chen, KC
    Yeh, CH
    Nunes, L
    Lin, GT
    Lin, CS
    Spencer, M
    Deng, D
    Lue, T
    JOURNAL OF UROLOGY, 2003, 169 (04): : 313 - 313
  • [7] Insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in women with premenstrual syndrome
    Rapkin, AJ
    Cedars, M
    Morgan, M
    Goldman, L
    FERTILITY AND STERILITY, 1998, 70 (06) : 1077 - 1080
  • [8] Variation in plasma insulin-like growth factor-1 and insulin-like growth factor binding protein-3: Genetic factors
    Morimoto, LM
    Newcomb, PA
    White, E
    Bigler, J
    Potter, JD
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (06) : 1394 - 1401
  • [10] Predictors of Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-Binding Protein-3 in Critical Illness
    Ahasic, Amy M.
    Tejera, Paula
    Wei, Yongyue
    Su, Li
    Mantzoros, Christos S.
    Bajwa, Ednan K.
    Thompson, B. Taylor
    Christiani, David C.
    CRITICAL CARE MEDICINE, 2015, 43 (12) : 2651 - 2659